Failure of Perivascular Drainage of -amyloid in Cerebral Amyloid Angiopathy

被引:123
|
作者
Hawkes, Cheryl A. [1 ]
Jayakody, Nimeshi [1 ]
Johnston, David A. [1 ]
Bechmann, Ingo [2 ]
Carare, Roxana O. [1 ]
机构
[1] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
[2] Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany
基金
英国生物技术与生命科学研究理事会;
关键词
Alzheimer's disease; amyloid; cerebral amyloid angiopathy; interstitial fluid neuroimmunology; perivascular drainage; CONVECTION-ENHANCED DELIVERY; INTERSTITIAL FLUID DRAINAGE; BETA FIBRIL FORMATION; ALZHEIMERS-DISEASE; A-BETA; APOLIPOPROTEIN-E; BASEMENT-MEMBRANES; TRANSFORMING GROWTH-FACTOR-BETA-1; CEREBROVASCULAR PATHOLOGY; SCAVENGER RECEPTOR;
D O I
10.1111/bpa.12159
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In Alzheimer's disease, amyloid- (A) accumulates as insoluble plaques in the brain and deposits in blood vessel walls as cerebral amyloid angiopathy (CAA). The severity of CAA correlates with the degree of cognitive decline in dementia. The distribution of A in the walls of capillaries and arteries in CAA suggests that A is deposited in the perivascular pathways by which interstitial fluid drains from the brain. Soluble A from the extracellular spaces of gray matter enters the basement membranes of capillaries and drains along the arterial basement membranes that surround smooth muscle cells toward the leptomeningeal arteries. The motive force for perivascular drainage is derived from arterial pulsations combined with the valve effect of proteins present in the arterial basement membranes. Physical and biochemical changes associated with arteriosclerosis, aging and possession of apolipoprotein E4 genotype lead to a failure of perivascular drainage of soluble proteins, including A. Perivascular cells associated with arteries and the lymphocytes recruited in the perivenous spaces contribute to the clearance of A. The failure of perivascular clearance of A may be a major factor in the accumulation of A in CAA and may have significant implications for the design of therapeutics for the treatment of Alzheimer's disease.
引用
收藏
页码:396 / 403
页数:8
相关论文
共 50 条
  • [41] Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction
    Gireud-Goss, Monica
    Mack, Alexis F.
    McCullough, Louise D.
    Urayama, Akihiko
    NEUROSCIENTIST, 2021, 27 (06) : 668 - 684
  • [42] Intracisternal injection of beta-amyloid seeds promotes cerebral amyloid angiopathy
    Yuan, Qiuju
    Xian, Yan-Fang
    Huang, Yan-feng
    Wu, Wutian
    Song, You-qiang
    Lin, Zhi-xiu
    BRAIN BEHAVIOR AND IMMUNITY, 2020, 89 : 628 - 640
  • [43] White Matter Perivascular Spaces Are Related to Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy
    Charidimou, Andreas
    Jaeger, Rolf H.
    Peeters, Andre
    Vandermeeren, Yves
    Laloux, Patrice
    Baron, Jean-Claude
    Werring, David J.
    STROKE, 2014, 45 (10) : 2930 - 2935
  • [44] Cerebral tau pathology in cerebral amyloid angiopathy
    Tsai, Hsin-Hsi
    Liu, Chia-Ju
    Lee, Bo-Ching
    Chen, Ya-Fang
    Yen, Ruoh-Fang
    Jeng, Jiann-Shing
    Tsai, Li-Kai
    BRAIN COMMUNICATIONS, 2024, 6 (02)
  • [45] Models of cerebral amyloid angiopathy-related intracerebral hemorrhage
    Vargas-George, Sebastian
    Dave, Kunjan R.
    BRAIN HEMORRHAGES, 2022, 3 (04): : 189 - 199
  • [46] Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy
    van den Berg, Emma
    Kersten, Iris
    Brinkmalm, Gunnar
    Johansson, Kjell
    de Kort, Anna M.
    Klijn, Catharina J. M.
    Schreuder, Floris H. B. M.
    Gobom, Johan
    Stoops, Erik
    Portelius, Erik
    Gkanatsiou, Eleni
    Zetterberg, Henrik
    Blennow, Kaj
    Kuiperij, Hinke B.
    Verbeek, Marcel M.
    JOURNAL OF NEUROCHEMISTRY, 2024, 168 (07) : 1254 - 1264
  • [47] Cerebral amyloid angiopathy as a cause of neurodegeneration
    Smith, Eric E.
    JOURNAL OF NEUROCHEMISTRY, 2018, 144 (05) : 651 - 658
  • [48] CLINICAL ASPECTS OF CEREBRAL AMYLOID ANGIOPATHY
    HAAN, J
    MAATSCHIEMAN, MLC
    ROOS, RAC
    DEMENTIA, 1994, 5 (3-4): : 210 - 213
  • [49] Fluid biomarkers in cerebral amyloid angiopathy
    Savar, Seyed Mehrdad
    Ma, Bin
    Hone, Eugene
    Jahan, Farzana
    Markovic, Shaun
    Pedrini, Steve
    Shemehsavar, Soudabeh
    Easwaran, Vandhana
    Taddei, Kevin
    Gardener, Samantha
    Chhatwal, Jasmeer P.
    van Etten, Ellis S.
    van Osch, Matthias J. P.
    Clarke, Daniel
    Gnjec, Anastazija
    van Buchem, Mark A.
    Wermer, Marieke J. H.
    Hankey, Graeme J.
    Greenberg, Steven M.
    Martins, Ralph N.
    Sohrabi, Hamid R.
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [50] Neuropsychological Effects of Cerebral Amyloid Angiopathy
    Schrag, Matthew
    Kirshner, Howard
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (08)